Xeris Biopharma Holdings, Inc. financial data

Symbol
XERS on Nasdaq
Location
Chicago, IL
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 06 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 182% % -8%
Quick Ratio 58% % 16%
Debt-to-equity -1682% % 22%
Return On Equity 74% % -81%
Return On Assets -4.7% % 76%
Operating Margin 3.7% %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 165,924,289 shares 11%
Common Stock, Shares, Outstanding 165,528,253 shares 11%
Entity Public Float $335,100,000 USD -7.3%
Common Stock, Value, Issued $17,000 USD 13%
Weighted Average Number of Shares Outstanding, Basic 163,649,932 shares 9.8%
Weighted Average Number of Shares Outstanding, Diluted 177,617,307 shares 19%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $266,137,000 USD 42%
Research and Development Expense $29,383,000 USD 14%
Operating Income (Loss) $9,802,000 USD
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $15,640,000 USD 75%
Earnings Per Share, Basic 0 USD/shares 80%
Earnings Per Share, Diluted 0 USD/shares 80%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $91,598,000 USD 55%
Accounts Receivable, after Allowance for Credit Loss, Current $53,751,000 USD 31%
Inventory, Net $67,462,000 USD 50%
Assets, Current $224,017,000 USD 38%
Property, Plant and Equipment, Net $4,946,000 USD -12%
Operating Lease, Right-of-Use Asset $22,263,000 USD -2.2%
Intangible Assets, Net (Excluding Goodwill) $90,789,000 USD -11%
Goodwill $22,859,000 USD 0%
Other Assets, Noncurrent $5,317,000 USD -2.3%
Assets $370,191,000 USD 15%
Accounts Payable, Current $6,527,000 USD -12%
Employee-related Liabilities, Current $20,148,000 USD 23%
Accrued Liabilities, Current $30,350,000 USD 29%
Liabilities, Current $116,200,000 USD 28%
Deferred Income Tax Liabilities, Net $0 USD -100%
Operating Lease, Liability, Noncurrent $31,991,000 USD -4.9%
Other Liabilities, Noncurrent $3,392,000 USD -60%
Liabilities $371,052,000 USD 6.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax $25,000 USD -56%
Retained Earnings (Accumulated Deficit) $682,388,000 USD -2.3%
Stockholders' Equity Attributable to Parent $861,000 USD 97%
Liabilities and Equity $370,191,000 USD 15%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $10,031,000 USD 51%
Net Cash Provided by (Used in) Financing Activities $3,137,000 USD -109%
Net Cash Provided by (Used in) Investing Activities $19,650,000 USD 55%
Common Stock, Shares Authorized 350,000,000 shares 0%
Common Stock, Shares, Issued 165,528,253 shares 11%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $13,181,000 USD -177%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $95,619,000 USD 51%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $199,165,000 USD 15%
Deferred Tax Assets, Gross $6,092,000 USD -67%
Operating Lease, Liability $38,185,000 USD -3.8%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $15,650,000 USD 75%
Lessee, Operating Lease, Liability, to be Paid $66,142,000 USD -8.4%
Property, Plant and Equipment, Gross $12,788,000 USD 1.8%
Operating Lease, Liability, Current $6,194,000 USD 2.5%
Lessee, Operating Lease, Liability, to be Paid, Year Two $6,389,000 USD 2.5%
Lessee, Operating Lease, Liability, to be Paid, Year One $6,232,000 USD 2.5%
Operating Lease, Weighted Average Discount Rate, Percent 0.12 pure 0%
Deferred Income Tax Expense (Benefit) $0 USD -100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $27,957,000 USD -14%
Lessee, Operating Lease, Liability, to be Paid, Year Three $6,549,000 USD 2.5%
Deferred Tax Assets, Operating Loss Carryforwards $116,743,000 USD -2.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25,000,000 shares 0%
Unrecognized Tax Benefits $712,000 USD 2.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four $6,714,000 USD 2.5%
Operating Lease, Payments $5,530,000 USD 92%
Additional Paid in Capital $681,535,000 USD 6.8%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets $10,843,000 USD 0%
Depreciation, Depletion and Amortization $315,000 USD -3.4%
Share-based Payment Arrangement, Expense $20,689,000 USD 18%
Interest Expense $27,425,000 USD 63%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%